ReviewEuropean cardiology2024

Dual-pathway Inhibition with Low-dose Aspirin and Rivaroxaban versus Aspirin Monotherapy in Patients with Coronary Artery Disease and Peripheral Artery Disease: Systematic Literature Review and Meta-analysis.

Dirk Sibbing et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.